The Oxford/AstraZeneca COVID-19 vaccine has been approved for use by the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria.
The vaccine was recently approved by the WHO for emergency use.
In a press briefing, NAFDAC says it got the dossier of the vaccine a week ago, and the NAFDAC safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.
Read the original article on Leadership.